MX385447B - Agente antihipertensivo - Google Patents

Agente antihipertensivo

Info

Publication number
MX385447B
MX385447B MX2017016096A MX2017016096A MX385447B MX 385447 B MX385447 B MX 385447B MX 2017016096 A MX2017016096 A MX 2017016096A MX 2017016096 A MX2017016096 A MX 2017016096A MX 385447 B MX385447 B MX 385447B
Authority
MX
Mexico
Prior art keywords
antihypertensive agent
blood pressure
lowering agent
safe
salt
Prior art date
Application number
MX2017016096A
Other languages
English (en)
Other versions
MX2017016096A (es
Inventor
Mitsuyasu Ushijima
Miyuki Takashima
Naoaki Morihara
Yukihiro Kodera
Original Assignee
Wakunaga Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharma Co Ltd filed Critical Wakunaga Pharma Co Ltd
Publication of MX2017016096A publication Critical patent/MX2017016096A/es
Publication of MX385447B publication Critical patent/MX385447B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
    • C07C321/18—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Se proporciona un agente antihipertensivo que es seguro y tiene un efecto ligero, un agente antihipertensivo, que comprende S-1-propenilcisteina o una sal del mismo como un ingrediente activo.
MX2017016096A 2015-06-12 2016-06-10 Agente antihipertensivo MX385447B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015119116 2015-06-12
PCT/JP2016/067320 WO2016199885A1 (ja) 2015-06-12 2016-06-10 血圧降下剤

Publications (2)

Publication Number Publication Date
MX2017016096A MX2017016096A (es) 2018-04-18
MX385447B true MX385447B (es) 2025-03-18

Family

ID=57503688

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017016096A MX385447B (es) 2015-06-12 2016-06-10 Agente antihipertensivo

Country Status (14)

Country Link
US (1) US10363234B2 (es)
EP (1) EP3308781B1 (es)
JP (1) JP6759199B2 (es)
AU (1) AU2016275642C1 (es)
CA (1) CA2989291C (es)
CO (1) CO2017012645A2 (es)
DK (1) DK3308781T3 (es)
ES (1) ES2904562T3 (es)
IL (1) IL255763B (es)
MX (1) MX385447B (es)
PT (1) PT3308781T (es)
SG (2) SG10201911876WA (es)
SI (1) SI3308781T1 (es)
WO (1) WO2016199885A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ760832A (en) * 2017-08-07 2025-12-19 Wakunaga Pharma Co Ltd Blood flow improver
JP7403446B2 (ja) 2018-06-07 2023-12-22 湧永製薬株式会社 オートファジー活性化剤
JP2020029529A (ja) * 2018-08-24 2020-02-27 日清ファルマ株式会社 抗酸化剤
US12403112B2 (en) 2019-05-14 2025-09-02 Wakunaga Pharmaceutical Co., Ltd. Agent for preventing, ameliorating, or treating periodontal disease
JP2021143132A (ja) * 2020-03-10 2021-09-24 株式会社ドアーズ アンジオテンシンｉ変換酵素阻害用組成物
WO2022043407A1 (fr) 2020-08-25 2022-03-03 Laouarem Yousra Compositions destinées au traitement des troubles neurologiques
CA3216695A1 (en) 2021-04-13 2022-10-20 Wakunaga Pharmaceutical Co., Ltd. Sirtuin or klotho activator or expression enhancer, nad+ increasing agent, and senolytic agent
CA3248430A1 (en) 2022-04-13 2025-07-09 Wakunaga Pharmaceutical Co., Ltd. Extracellular nicotinamide phosphoribosyltransferase enhancer, sirtuin activation or expression enhancer, nicotinamide adenine dinucleotide enhancer, and senescent cell inhibitor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2187326B1 (es) * 1972-06-15 1975-10-17 Rech Pharm Scientifiques
JPS62423A (ja) 1985-06-25 1987-01-06 Wakunaga Pharmaceut Co Ltd 肝疾患治療剤
JP4255138B2 (ja) 1996-05-24 2009-04-15 湧永製薬株式会社 脳疾患治療剤
JPWO2004077963A1 (ja) * 2003-03-04 2006-06-08 湧永製薬株式会社 植物加工物及びその製造法
CN1895607A (zh) 2005-07-12 2007-01-17 李甲怀 大蒜甙与大蒜生物活性成分组合物的提取工艺及其用途
JP4939781B2 (ja) 2005-08-10 2012-05-30 株式会社健康家族 ニンニク成分を含有する高血圧の予防及び／又は治療用組成物
GB0817393D0 (en) * 2008-09-23 2008-10-29 Givaudan Sa Flavour
DK3228312T3 (da) 2014-12-05 2020-04-20 Wakunaga Pharma Co Ltd Immunregulator

Also Published As

Publication number Publication date
MX2017016096A (es) 2018-04-18
PT3308781T (pt) 2022-03-09
US10363234B2 (en) 2019-07-30
SG10201911876WA (en) 2020-01-30
JPWO2016199885A1 (ja) 2018-03-29
AU2016275642C1 (en) 2020-09-17
JP6759199B2 (ja) 2020-09-23
IL255763B (en) 2020-11-30
DK3308781T3 (da) 2022-01-31
US20180147170A1 (en) 2018-05-31
CA2989291A1 (en) 2016-12-15
EP3308781A4 (en) 2019-01-23
ES2904562T3 (es) 2022-04-05
CO2017012645A2 (es) 2018-04-10
AU2016275642A1 (en) 2018-01-04
NZ738197A (en) 2024-08-30
SI3308781T1 (sl) 2022-04-29
IL255763A (en) 2018-01-31
AU2016275642B2 (en) 2020-04-30
SG11201710015UA (en) 2018-01-30
EP3308781A1 (en) 2018-04-18
WO2016199885A1 (ja) 2016-12-15
EP3308781B1 (en) 2022-01-12
CA2989291C (en) 2023-04-11

Similar Documents

Publication Publication Date Title
CO2019008487A2 (es) Compuesto de quinazolina
PL3896064T3 (pl) Pochodne 4,6-diamino-chinolino-3-karbonitrylu jako modulatory cot w leczeniu choroby leśniowskiego-crohna i wrzodziejącego zapalenia jelita grubego
JOP20200011B1 (ar) مركبات وتركيبات لمعالجة حالات مرضية مرتبطة بنشاط nlrp
IL256652A (en) Therapeutic compositions, combinations, and methods of use
IL257379A (en) Diacerein or its analogs for inhibiting expression of asc, nlrp3, and/or formation of nlrp3 inflammasome complex
IL268850A (en) Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases
MX378273B (es) Compuestos activos hacia bromodominios.
DK3889145T3 (da) 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme
IL249061B (en) Combination, composition, and method of administering the combination or composition to animals
IL255119B (en) Therapeutic pooled blood apoptotic cell preparations and uses thereof
EP3681479A4 (en) METHOD OF ADMINISTRATION AND TREATMENT
CA166574S (en) Blood pressure monitor
IL258259A (en) Adjunctive therapy with 25-hydroxyvitamin d and articles therefor
HUE060496T2 (hu) Terápiás vegyületek és készítmények szociális zavarok és szerhasználati zavarok kezelésére
IL253619A0 (en) Encapsulation of high potency active agents
IL261740A (en) Compositions and methods for treatment of type vii collagen deficiencies
MX2017016096A (es) Agente antihipertensivo.
UY36761A (es) Formulación oral sólida que contiene irinotecán y método 20 de preparación de la misma
IL269083A (en) Methods for preventing and treating heart disease
MX379359B (es) Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
MX2018008640A (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano.
EP3691621A4 (en) NEUPANEX ®: NEUROPROTECTIVE, NEUROREGENERATIONAL AND NEUROGENESIS SUPPLEMENTARY COMBINATION
IL266279B1 (en) Stable aqueous capsaicin injectable formuatlions and medical uses thereof
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
NZ760832A (en) Blood flow improver